Tesis por compendio / La presente tesis doctoral, que lleva por título “Diseño de nuevos nanomateriales híbridos con puertas moleculares como nanodispositivos para aplicaciones terapéuticas” está centrada en el desarrollo de nuevos materiales funcionales híbridos orgánico-inorgánicos para aplicaciones de liberación controlada. Los dos capítulos de la presente tesis en los que se describen los resultados obtenidos (el segundo y el tercer capítulos) están directamente relacionados con el uso de las nanopartículas mesoporosas de sílice como matriz inorgánica en el desarrollo de nuevos materiales híbridos orgánico-inorgánicos para aplicaciones en liberación controlada. Aun así, los resultados se han dividido en dos capítulos, dependiendo del estímulo aplicado para la liberación de la molécula encapsulada. En uno de los capítulos, los diferentes materiales desarrollados se basan en nanodispositivos controlados enzimáticamente, mientras que en el otro capítulo es un cambio de pH o de fuerza electroestática (en los dos casos debido a la presencia de un microorganismo patógeno) el que causa la consecuente liberación de la carga. En el caso de los nanodispositivos controlados enzimáticamente, los cuales se describen en el Capítulo 2, se desarrollaron tres sólidos diferentes. El primer ejemplo se basó en el diseño, síntesis y caracterización de nanopartículas mesoporosas de sílice recubiertas con sales de azopiridinio, que se hidrolizan en presencia de esterasas y reductasas, las cuales se encuentran en la microflora del colon. Estas sales, que contienen un enlace azoico, se seleccionaron para una posible liberación selectiva en el colon. Los estudios de viabilidad celular e internalización se llevaron a cabo con células HeLa, así como los estudios de liberación del agente quimioterapéutico camptotecina. Un segundo ejemplo se centró en el diseño, síntesis, caracterización y aplicaciones de un nuevo nanodispositivo que responde a la presencia de proteasas para liberación controlada, empleando nanopartículas de sílice cubiertas con el polímero -poli-L-lisina. En este caso, se pretendía evaluar dos mecanismos diferentes de anclaje del polímero y los dos dieron resultados positivos, aunque presentaron diferentes perfiles de liberación en cada caso. También se realizaron estudios de viabilidad e internalización celular con este nuevo nanodispositivo, así como la liberación de camptotecina en células HeLa. Finalmente, el último nanodispositivo que responde a la acción de un enzima; incluye el diseño y aplicación de un “scaffold” 3D inteligente con puertas moleculares, el cual consiste en la combinación de nanopartículas mesoporosas de sílice con puertas y biomateriales porosos clásicos. En este caso, las nanopartículas mesoporosas de sílice se cubrieron con poliaminas y ATP. Estas nanopartículas se incorporaron durante la síntesis de un “scaffold” de gelatina, el cual se preparó mediante técnicas de prototipado rápido (RP). En presencia de fosfatasa ácida se induce la liberación del colorante encapsulado en los poros de las nanopartículas. La fosfatasa ácida se seleccionó como estímulo activador de este material diseñado, ya que es un enzima cuya concentración se emplea para evaluar la actividad de los osteoclastos en procesos de remodelación ósea y como marcador en metástasis de huesos. Estas propiedades abren posibilidades de uso de esta combinación en el diseño de materiales funcionales para la preparación de numerosos “scaffolds” avanzados con puertas moleculares, que puedan ayudar en aplicaciones de medicina regenerativa y terapias de cáncer de huesos. Con respecto al otro tipo de nanodispositivos, que se muestra en el Capítulo 3, se ha evaluado el posible uso de las nanopartículas mesoporosas de sílice con puertas moleculares como posibles vehículos para la liberación controlada de fármacos cuando un microorganismo patógeno está presente. En este caso, el diseño y desarrollo de nuevos materiales híbridos orgánico-inorgánicos se ha basado en el uso de nanopartículas mesoporosas de sílice como matriz inorgánica, cubiertas con entidades moleculares orgánicas que podrían responder a un cambio en el pH del ambiente o a un cambio en la fuerza electroestática, debido a la presencia de un microorganismo patógeno, tales como hongos o bacterias. Uno de estos nanodispositivos desarrollados demuestra las aplicaciones y propiedades antifúngicas de un soporte cargado con tebuconazol y cubierto con moléculas que actúan de puerta molecular dirigida mediante un cambio de pH. El otro material presenta aplicaciones antibacterianas contra bacterias gram-positivas y gram-negativas, ya que se utiliza un nanodispositivo cargado con vancomicina y funcionalizado con -poli-L-lisina. En los dos casos, se ha demostrado que el uso de la nanoformulación puede mejorar la efectividad del fármaco encapsulado, mejorando y ampliando el espectro de acción del mismo, lo cual abre un gran abanico de posibilidades en aplicaciones de estos nanodispositivos en el tratamiento de infecciones. En resumen, se puede concluir que en la presente tesis se han desarrollado nuevos sólidos híbridos orgánico-inorgánicos, así como se han descrito las aplicaciones de estos nanodisposotivos como sistemas de liberación controlada. Los resultados obtenidos podrían ser útiles en futuros diseños de materiales híbridos avanzados en biotecnología, biomedicina y, concretamente, en aplicaciones terapéuticas (como terapias contra el cáncer, tratamiento de infecciones, medicina regenerativa, etc.) / Mas Font, N. (2014). Design of new hybrid nanomaterials with molecular gates as nanodevices for therapeutic applications [Tesis doctoral]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/48491 / Compendio

This research is the first systematic investigation of solid-state orientation as a novel method for controlling drug release from biodegradable polymers. The effect of various degrees of polymer orientation was studied in oriented Poly (L-lactic acid) (PLA) films containing curcumin and theophylline as model drugs. Additionally, direction specific drug release was studied from oriented PLA rods containing paracetamol. The films oriented to 2X uniaxial constant width (UCW) or 2X2Y biaxial draw ratio showed retardation of drug release, when their nematic structure was stabilised by the presence of crystalline theophylline. Contrarily, the same films when contained solid solution of curcumin, shrunk in the release medium and exhibited a release profile similar to the un-oriented films. All films oriented to the UCW draw ratio ≥ 3X contained α crystalline form of PLA and showed acceleration of drug release proportionate to the draw ratio. According to the proposed mechanism augmented formation of water filled channels in these films was responsible for faster drug release. Similarly, the paracetamol loaded PLA rods die-drawn to uniaxial draw ratios ≥ 3X exhibited enhancement of drug release. Importantly, the amount of drug released along the oriented chain axis was significantly larger than that in the perpendicular direction. Drug release from the die-drawn rods was accelerated by a greater degree than that observed from the oriented films. This can be correlated to the differences in their size, geometry and the crystalline form of PLA. In conclusion, the current study provided substantial evidence that solid-state orientation can offer a control over drug release from PLA.

The aim of this thesis was to examine the ability of metal organic frameworks (MOFs) to store and controllably release biologically significant amounts of nitric oxide (NO). Initial work involved the synthesis of a series of isostructural MOFs, known as M-CPO-27, which display coordinatively unsaturated metal sites (CUSs) when fully activated (guest solvent molecules both coordinated and uncoordinated to the metal atom are removed). Two of these frameworks (Ni and Co CPO-27) displayed exceptional performance over the entire cycle of activation, storage and delivery showing the largest storage and release of NO of any known porous material (up to 7 mmolg⁻¹). These frameworks would therefore be considered for initial research into the formulation of MOFs, for possible use in medical applications. It was shown that they still release large amounts of NO even when placed inside porous paper bags, creams or hydrocolloids. The other versions of M-CPO-27 also displayed significant adsorption of NO however they show poor total NO release. It was also shown that it is possible to synthesise both Ni and Co CPO-27 using microwave synthesis without any detrimental effect to the porous structure. Several iron-based MOFs were also investigated for NO storage and release. The results showed that Fe MIL-88 based structures adsorb good amounts of NO but only release a small amount of the irreversibly adsorbed NO. Two successfully amine grafted giant pore MOFs were then investigated to attempt to improve the NO adsorption and release. This result was not observed however, due to the poor total amine grafting coverage and pore blockage resulting from the amines. In-situ IR studies reveal that when exposed to NO, activated Fe MIL-100 forms a chemical bond with the NO. The studies also displayed that when water is then allowed to attempt to replace the NO that only a small amount of NO is actually released, the majority of the NO either remains chemically bonded to the Fe atom or forms N₂O in conjunction with a Fe-OH group. Other MOFs were also successfully synthesised and characterised for NO storage and release. Both Ni succinate and Ni STA-12 display good adsorption and excellent release of NO. This indicates that Ni based MOFs show the best results for NO adsorption and release. In the conclusion of the thesis I am able to categorise the NO release ability of MOFs based on composition and formulate a theory as to why this happens.

Background: Foam rolling (FR) is a promising new trend in the world of resistance training, sports and  athletics. It is often used as a warm up activity as a substitute or addition to  stretching modalities such as static stretching (SS). The proposed benefits behind FR is that it can lead to  both acute and chronic increases in performance and flexibility. Aim: The aim of this study was to investigate the effects of two different warm­up intervention protocols  of the hamstrings musculature on: 1) Performance in the bilateral standing long jump 2) Flexibility in a  supine active­knee­extension test. Method: The study consisted of sixteen male participants who were all healthy adult recreational athletes.  The two different interventions were, a) Static Stretching protocol (SS) and b) a Foam Rolling protocol  (FR). These were compared to a baseline warm up (BLWU). The SS consisted of 1 x 30 seconds of active  SS using the lying supine active­knee­extension position after a short warm­up. The FR consisted of 1  bout of 30 seconds of FR of the hamstrings musculature of each leg after a short warm­up. BLWU  consisted of a short warm­up (5 submaximal bilateral standing long jumps). Performance was measured  using a bilateral standing long jump test. Flexibility was measured with a goniometer using a lying supine active ­knee­ extension test. The student’s t­test was used to study differences between and within groups (BLWU, SS, FR). Results: No differences between BLWU and Post­SS (p=0.89) as well as BLWU compared to Post­FR (p=0.86) was detected for performance. However, an increase in flexibility was shown favoring Post­SS over BLWU (p=0.021) as well as Post­FR over BLWU (p=0.045). No significant difference was seen  between changes in the Post­SS and Post­FR groups in either performance or flexibility (p=0.887 and  p=0.944 respectively). Conclusion: It seems that both SS and FR are similarly viable and effective methods for acute increases  in flexibility in the active­knee­extension test without subsequent decreases in performance of the bilateral standing long jump.

Le travail de recherche mené au cours de cette thèse a été effectué dans le cadre d’une collaboration industrielle et a porté sur l’étude des caractéristiques physico-chimiques d’une matrice lipidique à libération prolongée. L’originalité de cette dernière tient à sa forme galénique, des microsphères calibrées d’environ 400 µm de diamètre, fabriquées par procédé de prilling puis conditionnées en sachets.Les caractérisations entreprises au cours de cette thèse ont été menées progressivement en partant de l’étude du comportement thermique individuel des constituants (excipients lipidiques et principe actif), puis de leurs mélanges pour définir les conditions d’existence et les caractéristiques structurales des phases solides qu’ils engendrent, notamment lors du prilling. Plusieurs diagrammes d’état partiels ont été construits pour permettre de cerner l’organisation de la matrice formant le produit fini et disposer de leviers fiables pour corriger d’éventuelles déviations du procédé de fabrication. Cette analyse était également indispensable pour décrire précisément le processus de libération du principe actif et en déterminer les paramètres cinétiques. / The research conducted in this thesis, during an industrial collaboration, is focused on the study of physicochemical characteristics of a sustained release lipid matrix. The originality of this matrix is its dosage form, microspheres of 400 microns in diameter, manufactured by a prilling process and packaged in stick-packs.The characterizations conducted during this thesis have been carried out gradually starting from the study of the thermal behavior of individual components (lipidic excipients and drug) and their mixtures to define the phase formation conditions and the structural characteristics of the solid phases generated, especially during the prilling process. Partial phase diagrams were constructed to understand the final product matrix organization and to identify actions to correct any deviations in the process. This analysis was also needed to accurately describe the drug release mechanism and to determine the kinetic parameters.

L’objectif général de cette thèse a été d’étudier le potentiel de billes à base de molécules d’α-cyclodextrine et d’huile de soja, pour l’administration orale de principes actifs peu solubles dans l’eau.Nous avons tout d’abord vérifié qu’il était possible d’encapsuler dans les billes des molécules actives (la progestérone et l’indométacine) autres que les rétinoïdes et le diazépam, avec une teneur élevée et un rendement de fabrication satisfaisant. L’étude du comportement des billes nues lyophilisées, en termes de stabilité et de libération dans des milieux digestifs simulés, nous a permis de proposer un mécanisme de libération de la molécule encapsulée qui se déroule en plusieurs étapes: i) hydratation des billes, ii) dissolution de la matrice hydrophile d’α-cyclodextrine, iii) libération de gouttelettes d’huile contenant le principe actif puis de la fraction dissoute dans l’huile par un phénomène de partage, iiii) fragmentation des billes fragilisées et libération totale de l’huile. La présence de sels biliaires dans le milieu, accélère à la fois la libération et la quantité dissoute, en fragilisant les billes et en réduisant la valeur du coefficient de partage du principe actif entre l’huile et le milieu digestif. Nous avons montré in vitro et in vivo qu’il est possible de moduler la libération d’un principe actif à partir d’une même formulation de départ, en jouant sur l’organisation du système (émulsion sèche, billes nues, billes coquées par un nouvel ajout d’α-cyclodextrine sur les billes nues). Les études in vivo chez le rat ont révélé que l’émulsion sèche se comporte comme une forme à libération immédiate, les billes coquées comme une forme à libération prolongée et les billes nues comme une forme à libération intermédiaire. Enfin, la libération du principe actif encapsulé peut également être modulée en modifiant le mode de séchage des billes. Comparativement à la lyophilisation, le séchage à l’étuve modifie les propriétés des billes en augmentant leur résistance dans les milieux digestifs simulés et prolonge la libération de la molécule encapsulée. / The general aim of this thesis was the study of the potential of beads, made of α-cyclodextrin and soybean oil, for the oral delivery of poorly water soluble drugs. We have first verified that it was possible to encapsulate in beads, active molecules (progesterone and indomethacin), other than retinoid and diazepam, with a high drug loading and a satisfying yied. The study of the behaviour of freeze-dried naked beads, in terms of stability and drug release in simulated gastro-intestinal fluids, allowed to propose a mechanism for the release of the encapsulated drug, involving several steps: i) hydration of the freeze-dried beads, ii) dissolution of α-CD hydrophilic matrix, iii) release of oily droplets containing the active drug and then of the fraction of drug dissolved in oil, following a partition phenomenon, iiii) fragmentation of the weakened beads and at last the total release of oil. The presence of bile salts in the medium accelerates both the release and the dissolved amount, by weakening the beads and reducing the partition coefficient value of the active molecule between oil and digestive medium.We have shown in vitro as well as in vivo that it is possible to modulate the release of a model drug from the same initial formulation, according to the degree of organization of the system (dry emulsion, naked beads, coated beads obtained by an additional amount of α-cyclodextrine to the preformed naked beads). In vivo studies in rats have highlighted that dry emulsion behaves as a fast release formulation, the coated beads as a sustained release formulation and the naked beads as an intermediate one. Finally, the release of the encapsulated drug can also be modulated by modifying the drying method of the beads. Compared to freeze-drying, oven-drying modifies the properties of the beads by increasing their resistance in simulated gastro-intestinal fluids and sustaining the release of the encapsulated drug.

Sedan implementeringen av on-load release funktionen på samtliga livbåtskrokar har det skett många olyckor som följd av introduktionen med detta system. Detta problem diskuterades under Internationella Maritima Organisationens Maritime Safety Committee, 89:e sammanträde 2011. Under detta sammanträde utvecklades ändringar och tillägg till koden för International Life-Saving Appliances med syfte att bemöta detta problem. Fokus för denna studien är resolution MSC.320(89) vilket formulerades under det sistnämnda mötet. Resolutionen lade fram nya krav rörande on-load release livbåtskrokar. Syftet med denna studie är att förstå hur MSC.320(89) har påverkat säkerheten vid hantering av livbåtar. Studien har utförts genom en kvalitativ litteraturstudie med komplementerande intervju. Genom att jämföra orsakande faktorer vid livbåtsolyckor med det nya kraven så har man kunnat spekulera fram positiva effekter gällande säkerheten. Implementeringsprocessen består av godkännande för utformning och funktion, rigorösa tester iland, samt granskningskrav för samtliga ombordvarande system. Minskning i antalet rapporter om olyckor vilket sker till följd av on-load release krokar efter implementeringsprocessen av MSC.320(89) tyder på att det sker ett färre antal olyckor relaterade till on-load release system. Denna minskning kan möjligtvis påverkas av implementeringen med fallprevention devices vilket kan ha som effekt att maskera svikt av on-load release system. Det övergripande resultatet från studien tyder på att MSC.320(89) har haft en positiv inverkan vad gäller säkerheten vid hantering av livbåtar. / There have occured many accidents as a result of the mandatory implementation of on-load release mechanisms on all lifeboats. In order to combat the problem amendments to the International Convention for the Safety of Life at Sea and the International Life-Saving Appliances Code were put forth during the Maritime Safety Committee, 89th session, 2011. The focus of this study lies on a product of this meeting: resolution MSC.320(89). The resolution presents new requirements for the design and function of on-load release systems. The purpose of this study is to understand how MSC.320(89) has influenced safety concerning the handling of lifeboats. A qualitative literature study with a complementary interview was used to conduct this study. By comparing causal factors of accidents involving on-load release systems with the new requirements stated in MSC.320(89) speculations could be made pertaining to improved safety conditions. The implementation process for the new requirements included a design review and performance test of existing and new on-load release and recovery systems. Moreover all systems onboard merchant vessels were either inspected, modified or replaced in order to be made compliant with the amended Life-Saving Appliance code. A decline in the number of accident reports concerning on-load release systems following implementation was observed during the data collection phase of this study. This decline may imply a reduction in the number of accidents caused by on-load release systems however the use of fall-prevention devices may have stopped failing on-load release systems from ending in catastrophe. The overriding conclusion of this study infers that resolution MSC.320(89) has effected safety concerning the handling of lifeboats in a positive manner.

Nearly 700,000 prisoners return to communities annually, and approximately two-thirds are rearrested within 3 years of release. The cyclic pattern of recidivism presents risks to both returning offenders and the communities that accept them. Reentry research tends to include the voice and experiences of juveniles, community members, and service providers, and narrowly focuses on the socioeconomic conditions of adult ex-offender populations pre- and post-release. Few researchers have explored the attitudes of those returning citizens or the perceived impact on treatment success, as related to employment-based, post-release reintegration programs. This study investigated the attitudes of 32 participants of Project Empowerment, the District of Columbia's post-release program. The ecology of public administration theory and empowerment theory provided the theoretical frameworks for understanding offender reentry within employment-based programming. Interview data were coded and analyzed consistent with a modified van Kaam method. A key finding indicates job-readiness training completion is largely contingent upon development of positive attitudes from both public administrators and participants. Additionally, participants were cognizant of the attitudes of community members regarding reentry and employment, and were more likely to see program participation as beneficial if perceived community support was high. The implications for positive social change include recommendations for reentry programs, such as Project Empowerment, to create an empowerment environment conducive to attitude development concerning self and society. Such an environment creates trust and opportunities for successful engagement in employment programs and decreases the risk of recidivism among communities that support individuals returning from incarceration.

La particule de reconnaissance du signal (signal recognition particle-SRP) et son récepteur (FtsY chez Escherichia coli) médiatise le processus simultané de traduction-ciblage de la protéine en dirigeant le complexe ribosome-nascent chain (RNCs) vers la membrane de destination. La reconnaissance par la SRP d'une charge RNC à transporter dépend de la présence de la partie N-terminale. L'assemblage de Ftsy au complexe RNC-PRS entraine plusieurs changements de configuration de SRP et de FtsY durant le cycle de direction. D'abord un stade « précoce » sans GTP est adopté. Celui-ci est stabilisé par le RNC. Ensuite une configuration « fermée » avec GTP est formée. Cette dernière peut s'activer pour hydrolyser GTP, elle entre alors dans sa configuration « active ». La succession de ces trois étapes conduit à la libération du complexe SRP-récepteur d'avec le ribosome et de sa protéine en cours de traduction, et leur mise à disposition au pore de la membrane. Dans ce projet, notre intérêt se limite à la traduction par le ribosome de la séquence signale EspP (RNCEspP). In vivo, EspP est une protéine dont le ciblage vers le récepteur membranaire se réalise après la traduction. Cependant il arrive que RNCEspP se lie au complexe SRP-FtsY, faisant échouer le ciblage. Nous avons étudié les bases structurales du rejet de RNCEspP par SRP et FtsY. Pour cela nous avons effectué la comparaison de la structure RNCEspP-SRP-FtsY obtenue par observation au cryo-microscope électronique avec d'autres complexes ribosome-SRP-récepteurs traduisant la charge FtsQ, qui est elle normalement ciblé par SRP. Nous avons cherché à observer la différence de structure entre les complexes SRP-FtsY dans les deux cas. Deux différences majeurs entre les complexes de ciblages contenants les séquences RNCFtsQ et RNCEspP ont été observés. Premièrement, dans le cas de la structure de RNCEspP le domaine M -Ffh est attaché à l'hélice 59 du ribosome, alors que celui-ci est détaché dans le cas de la structure de RNCFtsQ. Nous pensons que le domaine M empêche la libération de la séquence de signal, étape nécessaire à la réalisation du ciblage. Deuxièmement, dans le cas de la structure du complexe avec RNCEspP l'arrangement Ffh-FtsY avec le domaine NG était flexible. Ceci indiquerait que le complexe “précoce” formé sur RNCEspP est moins stable que celui formé sur RNCFtsQ. Une étude biochimique utilisant le transfert d'énergie via résonance fluorescente a corroboré ce résultat, montrant que FTS Y est lié avec une affinité moindre dans le cas du complexe précoce formé sur RNCEspP et que la reconfiguration au stade de complexe fermé est moins efficace. Une analyse biochimique plus poussée des variantes de la séquence de EspP montre que la partie N-Terminale de la séquence est la principale cause de rejet du cycle de ciblage via SRP.Dans un second projet, nous avons étudié la configuration “fermée” de SRP et ftsY en complexe avec une charge RNC stabilisée par un analogue non-hydrolysable de GTP (GMP-PCP). Pour franchir la barrière cinétique qui permet de passer du complexe précoce au complexe fermé, nous avons utilisé une version tronquée de FtsY, à laquelle la séquence terminale avait été amputée de tout le domaine acide (A-) ainsi que de la première hélice alpha du domaine NG. De plus, pour la formation du complexe, nous avons utilisé une construction contenant les 50 premiers acides aminés du leader peptidase (RNCLep50). En l'absence de nucléotides, notre reconstruction au cryo-EM a montré une configuration similaire à celle du stade précoce, dans laquelle Ftsy et Ffh- domaine NG, sont proche du tetraloop de la 4.5 S ARN. Une incubation avec GMP-PCP induit un détachement du domaine NG d'avec la queue du tetraloop. Il semblerait que les domaines NG soient flexibles dans l'état clos, et non attaché à la terminaison ouverte de l'ARN. / The signal recognition particle (SRP) and its receptor (FtsY in Escherichia coli) mediate co-translational protein targeting by delivering ribosome nascent chain complexes (RNCs) to the target membrane. Recognition of an RNC cargo by SRP is dependent on an N-terminal signal sequence. Binding of FtsY to the RNC-SRP complex leads to several conformational changes of SRP and FtsY during the targeting cycle: first, an “early” GTP-independent state is adopted which is stabilized by the RNC, subsequently a “closed” GTP- dependent conformation is formed which can activate itself to hydrolyze GTP (the “activated” state). Faithful completion of all three steps leads to release of the cargo from SRP-FtsY and hand over of the RNC to the translocation pore.It has been shown for E. coli that cargos can be rejected from the SRP pathway during all targeting steps. In the first project, our interest concentrates on ribosomes translating the EspP signal sequence (RNCEspP). In vivo, EspP is a post-translationally targeted protein, but RNCEspP has been shown to be bound by SRP and FtsY leading to a non-productive “early”-like RNCEspP-SRP-FtsY complex. Using single particle cryo-electron microscopy (EM), we analysed the structural basis for the rejection of RNCEspP by SRP and FtsY. Comparison of our RNCEspP-SRP-FtsY cryo-EM structure to other available cryo-EM structures of co-translational targeting complexes containing the correct cargo RNCFtsQ unravelled differences in the SRP-FtsY structure between a correct cargo and an incorrect cargo. Two major differences between the targeting complexes containing the cargos RNCFtsQ and RNCEspP were observed: first, the Ffh M-domain was attached to ribosomal RNA helix 59 of RNCEspP, while it was detached from this site in the case of RNCFtsQ. It could be that such an ordered M-domain is hampering the release of the signal sequence which is required for successful completion of targeting. Second, the Ffh-FtsY NG-domain arrangement was flexible in the complex with RNCEspP in comparison to RNCFtsQ indicating that the "early"-like complex formed on RNCEspP is less stable. Biochemical data using fluorescence resonance energy transfer corroborated these results, showing that FtsY is bound with lower affinity in the RNCEspP “early” complex and that the rearrangement to the “closed” conformation is less efficient. Further biochemical analysis of EspP signal sequence variants showed that mainly the N-terminal extension of the EspP signal sequence is responsible for its rejection from the SRP pathway.

The thrust of this thesis is to study oral solid dosage formulation using hot melt coating method and to use pharmacokinetic modeling and simulation (PK M&S) as a tool that can help to predict pharmacokinetics of a drug in human and the probability of passing various bioequivalence criteria of the formulation based on the PK of the drug. Hot-melt coating using a new method, direct blending, was performed to create immediate and sustained release formulations (IR and SR). This new method was introduced to offer another choice to produce IR and SR drug delivery formulations using single and double coating layer of waxes onto sugar beads and/or drug loaded pellets. Twelve waxes were applied to coat sugar cores. The harder the wax the slower the drug was released from single coated beads. The wax coating can be deposited up to 28% of the weight of the core bead with 58% drug loading efficiency in the coating The cores were coated with single or double wax layers containing acetaminophen. Carnauba wax coated beads dissolved in approximately 6 hrs releasing 80% of loaded drug. However, when covered with another layer, the drug loaded beads released drug for over 20 hrs. When drug loaded pellets were used as cores, 33-58% drug loading was achieved. Double coated pellets exhibited a near zero order drug release for up to 16 hrs. Hot melt coating by direct blending using waxes is a simple process compared to conventional hot melt coating using coating pan or fluid bed coating machines. It offers an alternative way of making immediate, sustained drug release (IR, SR) and modified release (IR+SR) oral dosage forms of drugs which are stable at high temperature (100°C). The pellet-containing-drug coated formulations provide options when higher drug loading is warranted. It is required by the US Food and Drug Administration (FDA) that a new modified –release (MR) product or identical generic product be regarded as bioequivalent (BE) to the originators reference drug product. However, there are concerns that current regulatory criteria are not sufficient when evaluating bioequivalence (BE) for many MR products, and additional metrics for BE assessment of the products should be applied to ensure therapeutic equivalence. This study used pharmacokinetic modeling and simulation (M&S) to investigate 1) the probability of BE occurring between the MR test and reference products 2) the rates of false positive and true negative of the BE test; and 3) the estimation of the sample size in pivotal BE studies; all of which when partial area under the curves (pAUCs) were applied as additional BE criteria. Reference data of two MR forms of methylphenydate HCl (MPH) were simulated and obtained from literature (formulation Q and Metadate CD, respectively). Monte Carlo simulations were performed to simulate the test drug concentration profiles and BE assessment was carried out utilizing the mean (method 1) and individual concentration time curves (method 2). For formulation Q, adding pAUC₀₋[subscript Tmax] to current BE criteria reduced the possibility of passing BE from approximately 98% to 85%, with a true negative rate of 5%. The earlier the time points used to determine for pAUC before Tmax, the lower the chance of passing BE for the test product. The possibility of passing BE varied and depended on the coefficient of variations (CV) of T[subscript lag], K[subscript a] and K[subscript e] and that considerable variability in the parameters affected the earlier segments of the drug concentration profile curves more. Similar drug concentration time profiles between the test and reference products is recommended to ensure bioequivalence occurs with a reasonable subject sample size. A similar scenario was seen when Metadate CD was used as the reference product. PK M&S can help provide appropriate additional metrics to assure the BE test is a better tool ensuring therapeutic equivalence for MR products with little negative impact to generic manufacturers. Predictions can also be made about the required sample size and the chances of passing BE with any addition to the conventional three criteria for the test product. PK M&S was also used to predict drug concentrations of levofloxacin in tissue. Levofloxacin has been widely used in clinical practice as an effective broad-spectrum antimicrobial, however tendonitis and tendon rupture have been reported with increasing use of this agent. Here, these incidents will be assessed by investigating pharmacokinetic behavior of the compound to see if they are related to drug's tissue disposition. The PK model for levofloxacin was established. Mean concentration time profiles of single or multiple dosing of 500 mg levofloxacin following oral and IV infusion administration were simulated. Monte Carlo simulation was used to simulate the drug concentration time profiles in plasma (compartment 1) and tissue (compartment 2) after seven dosing regimens while varying the drug's elimination and distribution rates to see the effect of changing those rates have on the drug accumulation in tissue. Monte Carlo Simulation shows that low elimination rates affect the drug concentration in plasma and tissue significantly with the level in plasma rising up to 35 μg/mL at day 7. A normal elimination rate together with escalation of distribution rates from plasma to tissue could increase the tissue concentration after 7 doses to 9.5 µg/mL, a value that is more than twice that of normal. PK M&S can be used as an effective tool to evaluate drug concentration in different compartments (plasma and tissues, for example). The unexpectedly high concentration values in some cases may explain, at least in part, the reason of tendinopathy occurs in the clinical setting. / Graduation date: 2012 / Access restricted to the OSU Community at author's request from June 7, 2012 - June 7, 2014